Volufiline in Skincare
Volufiline is a trademarked emollient and skin-conditioning blend marketed for plumping. Meaningful facial-volume restoration is not established; high percentages describe the supplier blend, not pure botanical active.
- Ingredient category
- Conditioning Agent, Emollient
- Most relevant for
- Fine Lines and Wrinkles
- Evidence strength
- Not Established for Restoring meaningful visible facial volume with ordinary topical Volufiline skincare
- Formula matters
- Volufiline is a carrier-and-botanical raw-material blend, so a headline percentage reflects the blend rather than pure plant extract or sarsasapogenin; finished facial-product testing matters more than the number.
- Separate product needed?
- Usually No. A separate Volufiline serum is optional; it makes sense only when the formula and price work for you without relying on guaranteed volume restoration.
BB takeaway
Volufiline has an interesting adipocyte mechanism but does not have strong human evidence for restoring facial fat or working like filler. Judge the finished formula rather than paying more for a large percentage alone.
Ingredient evidence does not prove the performance of every finished product containing it.
What is Volufiline?
Volufiline™ is a trademarked cosmetic raw-material blend from Sederma/Croda Beauty, not the INCI name of one standalone molecule. Croda currently lists it as Hydrogenated Polyisobutene (and) Anemarrhenae Asphodeloides (Root) Extract and classifies it as a skin-conditioning ingredient.[1]
Hydrogenated polyisobutene is an oily emollient carrier. The botanical portion comes from Anemarrhena asphodeloides root. Supplier research around Volufiline focuses on sarsasapogenin, a compound associated with the plant extract.
Those components are not aliases for Volufiline. A product can contain hydrogenated polyisobutene or Anemarrhena asphodeloides root extract without necessarily using the trademarked Volufiline raw material.
What does Volufiline do for skin?
The most predictable cosmetic contribution is emollience: the hydrogenated polyisobutene base can make skin feel softer and look smoother.
The more ambitious claim is visible volume. Croda markets Volufiline around adipose-tissue formation, lipid storage, and adipocyte differentiation to promote a fuller look.[1]
That mechanism is why Volufiline is sometimes described online as “filler in a bottle” or a topical fat-restoring ingredient. The current human evidence does not establish that an ordinary facial serum restores lost facial fat, fills under-eye hollows, or works like injectable filler.
If a Volufiline product makes skin look smoother right away, the oily base, moisturization, and surface light reflection are more plausible explanations than newly formed facial fat.
What the evidence says about Volufiline skincare
Meaningful facial-volume restoration is not established.
The supplier-origin patent behind the sarsasapogenin concept includes laboratory studies showing adipogenic and lipogenic activity in cells.[2] That demonstrates a biological mechanism under laboratory conditions, not that enough active material reaches facial fat through intact skin during normal cosmetic use.
The patent also reports a single-blind treated-breast study. Of 32 women enrolled, 28 were evaluable at day 56. The treated side received a cream-gel described as containing 5% sarsasapogenin twice daily, while the other breast was untreated.[2]
Average treated-side volume increased 1.4% after 28 days and 2.2% after 56 days. The reported p values were 0.30 and 0.10, so the average changes did not meet the conventional p<0.05 threshold.[2]
That is weak evidence for facial skincare. The study was small, tested the breast rather than the face, used an untreated comparison rather than the same cream base without the active, and appears in a supplier patent rather than a peer-reviewed clinical paper.
It should also not be described casually as a “5% Volufiline study.” The patent states that the test cream contained 5% sarsasapogenin, while today’s Volufiline raw material is a blend of hydrogenated polyisobutene and Anemarrhena asphodeloides root extract.
As of October 2026, no robust peer-reviewed controlled trial establishes meaningful restoration of facial volume in the cheeks, temples, lips, or under-eye hollows from ordinary topical Volufiline use.
How Volufiline form and formulation affect results
Volufiline is a raw-material blend, so percentage claims are easy to misread.
A product labeled “5% Volufiline” is describing the amount of the supplier blend, not 5% pure Anemarrhena asphodeloides extract or 5% sarsasapogenin. Those numbers are not interchangeable.
That distinction matters with today’s high-percentage formulas. The Ordinary currently sells a facial serum labeled 92% Volufiline™. Its ingredient list begins with hydrogenated polyisobutene and also includes Anemarrhena asphodeloides root extract.[3] The 92% claim refers to the trademarked raw-material blend, not 92% plant extract or sarsasapogenin.
Vehicle, the raw-material specification, other emollients, contact time, delivery, and the anatomical area all affect what a finished product might do.
Seeing both Volufiline INCI components on an ingredient list also does not prove that a brand used the trademarked material at the supplier’s specification. Finished-product testing on the face is more useful than a large front-label percentage.
Who may benefit from Volufiline skincare?
Volufiline may appeal if you want to experiment with a targeted plumping serum and understand that meaningful facial-volume evidence is not established.
It may also suit you if you like rich, oily textures and mainly want softer, smoother-looking skin in areas that appear dry or crepey.
It is a poor fit if you expect a topical product to correct pronounced under-eye hollows, temple hollowing, cheek-volume loss, or other structural facial aging. Those changes can involve bone, deeper fat compartments, ligaments, muscle, and skin—not just the surface.
If dryness is the real concern, a simpler moisturizer may provide a more predictable benefit.
Volufiline side effects and irritation risk
Published safety information on the complete trademarked blend is limited, so tolerability should be judged at the finished-product level.
Hydrogenated polyisobutene has a longer cosmetic safety record. The Cosmetic Ingredient Review Expert Panel concluded that polyisobutene and hydrogenated polyisobutene are safe in cosmetics under the practices of use and concentrations described in its assessment.[4]
That conclusion applies to the carrier ingredient, not automatically to every Anemarrhena extract, every Volufiline specification, or every finished serum.
The complete product can still cause stinging, itching, redness, breakouts, or a rash because of other ingredients or because a rich oily texture does not suit your skin.
Be cautious around the eyes. The commonly cited human volume study did not test the under-eye area, and an oily or rich formula can make some people look puffier rather than less hollow.
Stop using a product that causes persistent burning, swelling, severe itching, blistering, or a worsening rash.
How to use Volufiline in your skincare routine
Use the finished product according to its directions rather than buying bulk raw material and trying to formulate your own version.
Because Volufiline is oil based, some targeted serums are applied after moisturizer or near the end of the routine. Follow the product’s instructions rather than a universal layering rule.
Use only on intact skin unless a qualified clinician specifically instructs otherwise. Do not apply a cosmetic plumping serum to open wounds, fresh procedure sites, or the wet lash line.
During the day, broad-spectrum sunscreen remains more important for preventing visible photoaging than any volumizing cosmetic.
How long does Volufiline take to work?
There is no dependable facial-results timeline.
The supplier-origin breast study measured changes after 28 and 56 days of twice-daily use.[2] Because it did not test the face and the average changes were not conventionally statistically significant, those time points should not be turned into a promise that a facial serum will restore volume in four or eight weeks.
If a product makes skin look smoother immediately, the emollient base or other moisturizing ingredients are the more plausible explanation.
If a brand promises a precise timeline for cheek, temple, lip, or under-eye volume, look for controlled testing on that exact finished facial product.
What can you use with Volufiline?
There is no established universal incompatibility between Volufiline and common skincare ingredients.
It can sit in routines with niacinamide, vitamin C, peptides, retinoids, or exfoliating acids when the complete routine remains comfortable.
The more practical concern is texture and irritation. An oily Volufiline serum layered over several rich products may feel heavy, while retinoids or acids may make the same area more sensitive.
If irritation develops, simplify the routine rather than assuming Volufiline needs a special compatibility workaround.
How to choose a Volufiline product
Start by checking whether the brand clearly identifies Volufiline™ rather than simply listing one of its components.
Then ask what any highlighted percentage actually measures. A large Volufiline number is the percentage of the raw-material blend, not the percentage of pure botanical extract or sarsasapogenin.
Give the most weight to testing on the exact finished product and the exact area you plan to treat. A cell study, supplier patent, breast study, or consumer selfie is much weaker evidence for under-eye or cheek volume than a controlled facial trial.
Be cautious with “filler in a bottle,” “restores facial fat,” “rebuilds lost volume,” “lipofilling without injections,” and “permanent plumping” claims. The current human evidence does not establish those outcomes.
Also judge the ordinary formula. If the product mainly behaves like an oily emollient, ask whether you like the texture and whether the price still makes sense without guaranteed volume change.
Volufiline alone does not justify Premium pricing. Pay more only when the finished formula offers a meaningful advantage in texture, tolerability, packaging, or credible product-level testing.
Do you need a separate Volufiline serum?
Usually, no.
A dedicated Volufiline serum is best treated as an optional experiment, not a foundational skincare step.
It can make sense if you are curious about subtle cosmetic plumping, understand the evidence gap, and the price feels reasonable even if the main benefit turns out to be softness and surface smoothing.
If your goal is meaningful correction of facial-volume loss, topical Volufiline does not have comparable evidence to established in-office approaches. If your goal is simply smoother dry skin, a good moisturizer is the more predictable purchase.
The BB Perspective
Volufiline is a good example of why a strong mechanism and a large percentage do not automatically make a strong skincare claim.
The blend has an interesting adipocyte story and supplier-origin human data, but the human study is small, breast-based, non-peer-reviewed, and did not reach conventional statistical significance for the average volume change. That is not enough to establish facial fat restoration from ordinary topical use.
For your routine, Volufiline is best treated as an optional skin-conditioning and emollient blend. Buy the finished product only if its texture, price, and product-level evidence make sense without relying on the promise of topical facial fat restoration.
Last reviewed: August 2026
Sources
Croda’s current supplier page identifies the Volufiline INCI as Hydrogenated Polyisobutene (and) Anemarrhenae Asphodeloides (Root) Extract and lists skin conditioning among its functions. The page also promotes an adipose-tissue-related plumping mechanism. Because Croda sells the ingredient, this is a primary source for identity and supplier claims rather than independent efficacy evidence. Return to citation.
Sederma SAS. Composition comprising sarsasapogenin. U.S. Patent 8,361,516.
This supplier-origin patent describes sarsasapogenin in hydrogenated polyisobutene, adipocyte laboratory experiments, and a single-blind treated-breast study. Thirty-two women were enrolled and 28 were evaluable at day 56. The patent reports average treated-side volume changes of 1.4% at day 28 and 2.2% at day 56, with p values of 0.30 and 0.10. The study was not a peer-reviewed facial trial and did not use a matching vehicle control. It should not be treated as proof of meaningful facial-volume restoration from modern Volufiline cosmetics. Return to citation.
The Ordinary. Volufiline 92% + Pal-Isoleucine 1% Plumping Serum.
This current U.S. product page is included only to illustrate percentage labeling. The brand identifies the finished product as containing 92% Volufiline and lists hydrogenated polyisobutene first, with Anemarrhena Asphodeloides Root Extract later in the ingredient list. The example shows why a headline Volufiline percentage represents the trademarked raw-material blend rather than the same percentage of pure plant extract or sarsasapogenin. It is not used as independent proof that Volufiline restores facial volume. Return to citation.
Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of Polyisobutene and Hydrogenated Polyisobutene as used in cosmetics. International Journal of Toxicology. 2008;27(Suppl 4):83-106.
This safety assessment covers polyisobutene and hydrogenated polyisobutene and concluded they were safe in the cosmetic practices of use and concentrations described. It supports the safety context for Volufiline’s oily carrier but does not assess the complete Volufiline blend, the botanical extract, or claims about facial volume. Cosmetic Ingredient Review is funded by the Personal Care Products Council, a cosmetics-industry trade association. Return to citation.